ADB signs US$1bn capacity deal with Tokio Marine, Chubb, Liberty, Allianz and Axa XL
August 19 2022 by Andrew Tjaardstra
-
Canopius’ APAC expansion builds around specialty lines demand
- November 1
The priority for Canopius is to maintain disciplined growth in the specialty lines where it has a differentiated offering, like energy, marine, agriculture treaty, and structured credit, says regional chief executive SK Lee.
-
Seoul Guarantee Insurance’s H1 loss ratios worsen as claims surge: report
- October 8
Total claims paid out in the first six months reached nearly US$400m, an all-time high, and is expected to nearly double by the end of 2024.
-
Mega Insurance COR up 10 points to 97% as credit, motor claims climb
- August 22
Fitch Ratings has affirmed an insurer rating of 'A+ for the company with a stable outlook as its GWP rose 75% in 2023.
-
Texel names Coface’s Hélène Heas as broker for Asia operations
- August 21
Singapore-based Heas will be supporting the broker's business growth across the Asia Pacific region and further enhance its client solutions and market reach.
-
BHSI | Managing non-Asian exposure in long-tail lines
While US-exposed business can look attractive to Asian carriers, managing the volatility around the long-term results and the ability to model those losses are crucial, say BHSI’s Marc Breuil and Marcus Portbury.
-
Sedgwick | To Handle CAT Claims Well, Multi-Step Preparation is Key
When it comes to risk, it’s not a matter of “if” it’s a matter of “when” an event will occur.
-
HSBC Asset Management | Is it time to relook at Asian currency bonds?
With diversification and performance high on investors’ agendas, it seems a good time for global portfolios to revive allocations in Asian local currency bonds – including Hong Kong dollar (HKD) bonds.
-
PineBridge Investments | Why Asian insurers are exploring private credit and CLOs
The recent rollout of risk-based capital regimes across Asia calls for a closer alignment between insurers’ assets and liabilities. We explore potential ways to maintain a healthy investment yield and robust returns on regulatory capital.
